Gufic Biosciences Announces 42nd Annual General Meeting, Declares Dividend, and Re-appoints Directors
Gufic Biosciences Limited has scheduled its 42nd Annual General Meeting (AGM) for Friday, September 04, 2026. The meeting will be held via Video Conferencing (VC) / Other Audio Visual Means (OAVM).The AGM is slated to transact ordinary and special business, including the adoption of financial statements, declaration of a final dividend, and key director appointments, according to the company notice dated July 31, 2026.
Key Business Resolutions
Among the main agenda items for the meeting are:
- Financial Matters: To consider and adopt the Audited Standalone Financial Statements and the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026.
- Dividend Declaration: To declare a Final Dividend at 10%, which amounts to ₹ 0.10 per equity share of the face value of ₹ 1/- each for the Financial Year ending March 31, 2026.
- Director Reappointment: To appoint a Director in place of Mr. Pranav J. Choksi, who retires by rotation and is eligible for re-appointment.
In addition to ordinary business, the AGM will address two special resolutions:
- Cost Auditor Ratification: Members are sought to ratify the remuneration payable to M/s. Poddar & Co. (FRN: 101734), Cost Auditors, for the Financial Year ending March 31, 2027. The proposed remuneration is ₹ 4,00,000 per annum plus applicable taxes and reimbursement of actual travel and out of pocket expenses incurred in connection with the audit.
- Director Reappointment: A special resolution seeks approval for the re-appointment of Mr. Pankaj J. Gandhi (DIN: 00001858) as a Whole Time Director (WTD). The proposed tenure is for five years, commencing from September 07, 2026, until September 06, 2031.
Director Appointment Details and Governance
The Board of Directors has approved the re-appointment of Mr. Pankaj J. Gandhi as WTD. His appointment terms include a salary not exceeding ₹ 100,00,000/- per annum, in addition to specified perquisites and allowances. The company's total managerial remuneration is subject to limits set by Section 197 of the Companies Act.
The Board meeting held on July 31, 2026, also approved the re-appointment of Mr. Pranav J. Choksi for his role as Director.
| Director Name | Relevant Notice Item | Age (Years) | Expertise Area |
|---|---|---|---|
| Mr. Pranav J. Choksi | 3 | 43 | Specialization in Autologous Cancer Vaccines and business development. |
| Mr. Pankaj Jayakumar Gandhi | 5 | 67 | Rich experience in liaisoning with Regulatory Authorities. |
Mr. Pranav J. Choksi, who has been with the company since June 25, 2004, holds 72,68,626 equity shares in Gufic Biosciences Limited. Mr. Pankaj Gandhi is being re-appointed for a term of five years and currently holds nil shareholding in the company.
Record Date and Book Closure
The Register of Members and Share Transfer Books of Gufic Biosciences Limited will remain closed from Saturday, August 29, 2026, to Friday, September 04, 2026 (both days inclusive). The record date for the AGM and the payment of the final dividend is set as Friday, August 28, 2026.
GUFICBIO Stock Price Movement
Gufic Biosciences Limited shares slipped by 1.18% on Wednesday, settling at ₹424.90 as the company closed for the session. The stock experienced intraday volatility, trading between a high of ₹439.0 and a low of ₹420.3.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.